UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3104) 3104
Newspaper Article (163) 163
Book Chapter (65) 65
Newsletter (65) 65
Dissertation (8) 8
Magazine Article (4) 4
Publication (2) 2
Book / eBook (1) 1
Conference Proceeding (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2361) 2361
neuroblastoma (2355) 2355
science & technology (2184) 2184
life sciences & biomedicine (2011) 2011
oncology (1214) 1214
female (1194) 1194
infant (1160) 1160
male (1140) 1140
neuroblastoma - mortality (1132) 1132
child (1082) 1082
child, preschool (1070) 1070
neuroblastoma - pathology (898) 898
prognosis (748) 748
pediatrics (698) 698
cancer (645) 645
adolescent (572) 572
tumors (553) 553
neuroblastoma - genetics (505) 505
neuroblastoma - therapy (495) 495
cell line, tumor (469) 469
neoplasm staging (439) 439
animals (420) 420
apoptosis (419) 419
survival rate (419) 419
infant, newborn (406) 406
research (395) 395
neuroblastoma - drug therapy (393) 393
chemotherapy (378) 378
proteins (348) 348
retrospective studies (337) 337
surgery (328) 328
neuroblastoma - metabolism (321) 321
gene expression (312) 312
health aspects (312) 312
mice (297) 297
children (296) 296
metastasis (296) 296
treatment outcome (296) 296
adult (285) 285
hematology (285) 285
survival analysis (283) 283
care and treatment (280) 280
neuroblastoma - diagnosis (280) 280
risk factors (272) 272
neuroblastoma - surgery (263) 263
mortality (262) 262
medical prognosis (257) 257
abridged index medicus (256) 256
analysis (242) 242
combined modality therapy (240) 240
kinases (235) 235
patients (234) 234
cancer therapies (229) 229
medicine (229) 229
disease-free survival (227) 227
research article (217) 217
follow-up studies (214) 214
antineoplastic combined chemotherapy protocols - therapeutic use (209) 209
cell biology (208) 208
genetic aspects (208) 208
age factors (191) 191
gene expression regulation, neoplastic (183) 183
science & technology - other topics (178) 178
survival (176) 176
time factors (170) 170
cell cycle (169) 169
development and progression (169) 169
multidisciplinary sciences (165) 165
neuroblastoma - epidemiology (163) 163
studies (162) 162
signal transduction (161) 161
diagnosis (160) 160
biochemistry & molecular biology (159) 159
cell proliferation (159) 159
stem cells (157) 157
gene amplification (156) 156
middle aged (148) 148
cell growth (146) 146
incidence (146) 146
neuroblastoma cells (145) 145
mutation (144) 144
medical research (143) 143
science (143) 143
pathology (142) 142
kaplan-meier estimate (139) 139
immunohistochemistry (136) 136
neurosciences & neurology (135) 135
apoptosis - drug effects (130) 130
cell death (130) 130
medicine & public health (129) 129
n-myc proto-oncogene protein (129) 129
biology (127) 127
medicine, research & experimental (127) 127
research & experimental medicine (127) 127
nervous system (124) 124
neurosciences (123) 123
age (122) 122
cytotoxicity (117) 117
nuclear proteins - genetics (117) 117
antineoplastic agents - therapeutic use (116) 116
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3304) 3304
German (43) 43
French (19) 19
Spanish (18) 18
Japanese (17) 17
Italian (12) 12
Russian (12) 12
Chinese (9) 9
Norwegian (5) 5
Portuguese (5) 5
Danish (4) 4
Polish (2) 2
Turkish (2) 2
Bulgarian (1) 1
Dutch (1) 1
Serbian (1) 1
Slovenian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 16, pp. e604 - e610
Journal Article
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 2016, Volume 67, pp. 130 - 140
Abstract Objectives Dose-finding trials are fundamental to develop novel drugs for children and adolescents with advanced cancer. It is crucial to maximise... 
Hematology, Oncology and Palliative Medicine | Innovative Therapies for Children with Cancer | Dose-finding trial | Prognostic factor | Phase I trial | Children | Adolescents | Survival | Life Sciences & Biomedicine | Oncology | Science & Technology | Osteosarcoma - drug therapy | Multivariate Analysis | Prognosis | Neuroectodermal Tumors, Primitive - drug therapy | Humans | Child, Preschool | Infant | Male | Neuroblastoma - mortality | Sarcoma, Ewing - mortality | Medulloblastoma - mortality | Ependymoma - drug therapy | Employment | Ependymoma - mortality | Sarcoma - mortality | Female | Rhabdomyosarcoma - drug therapy | Retrospective Studies | Child | Rhabdomyosarcoma - mortality | Schools | Osteosarcoma - mortality | Glioma - mortality | Neuroectodermal Tumors, Primitive - mortality | Europe | Proportional Hazards Models | Neoplasms - mortality | Therapies, Investigational | Survival Rate | Sarcoma - drug therapy | Neoplasms - drug therapy | Sarcoma, Ewing - drug therapy | Neuroblastoma - drug therapy | Adolescent | Medulloblastoma - drug therapy | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Clinical Trials, Phase I as Topic | Glioma - drug therapy | Care and treatment | Patient outcomes | Children's hospitals | Oncology, Experimental | Clinical trials | Research | Health aspects | Cancer | Index Medicus
Journal Article
Scientific reports, ISSN 2045-2322, 07/2020, Volume 10, Issue 1, pp. 10761 - 10761
.... We collected and analized data on late mortality, secondary malignancies and cardiac diseases in survivors (>5 years... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Osteosarcoma | Mortality | Death | Children | Solid tumors | Neuroblastoma | Cardiovascular diseases | Health risk assessment | Heart diseases | Coronary artery disease | Hodgkin's disease | Cancer | Index Medicus
Journal Article
Cancer, ISSN 1097-0142, 12/2018, Volume 125, Issue 7, pp. 1050 - 1059
Background Primary malignancies of the adrenal glands are rare. Epidemiologic assessment of primary adrenal malignancies is lacking and has been limited to... 
neuroblastoma | pheochromocytoma | outcomes | adrenal cancer | survival | Life Sciences & Biomedicine | Oncology | Science & Technology | United States - epidemiology | Adrenal Cortex Neoplasms - epidemiology | Adrenocortical Carcinoma - epidemiology | Age Distribution | Humans | Middle Aged | Child, Preschool | Infant | Male | Antineoplastic Agents - therapeutic use | Neuroblastoma - mortality | Neuroblastoma - therapy | Pheochromocytoma - mortality | Sarcoma - therapy | Incidence | Adrenal Gland Neoplasms - mortality | Adrenal Gland Neoplasms - epidemiology | Paraganglioma - mortality | Sarcoma - mortality | Aged, 80 and over | Adult | Female | Neuroblastoma - epidemiology | Paraganglioma - epidemiology | Adrenocortical Carcinoma - mortality | Child | Adrenal Cortex Neoplasms - mortality | Pheochromocytoma - epidemiology | SEER Program | Paraganglioma - therapy | Survival Rate | Combined Modality Therapy | Lymphoma, Non-Hodgkin - epidemiology | Adrenocortical Carcinoma - therapy | Adrenal Cortex Neoplasms - therapy | Adrenalectomy | Lymphoma, Non-Hodgkin - therapy | Aged | Lymphoma, Non-Hodgkin - mortality | Sarcoma - epidemiology | Pheochromocytoma - therapy | Adrenal Gland Neoplasms - therapy | Pheochromocytoma | Sarcoma | Adrenal glands | Paraganglioma | Case reports | Neuroblastoma | Epidemiology | Patients | Survival | Lymphoma | Medical prognosis | Age | Hodgkin's disease | Age composition | Index Medicus | Abridged Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 03/2020, Volume 21, Issue 3, pp. 421 - 435
.... We aimed to describe chronic health conditions and all-cause and cause-specific mortality among survivors of early-adolescent and young adult cancer... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Index Medicus
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2002, Volume 20, Issue 5, pp. 1209 - 1214
Journal Article
Cancer, ISSN 0008-543X, 10/2017, Volume 123, Issue 19, pp. 3807 - 3815
BACKGROUND Programmed death 1 (PD‐1) signaling in the tumor microenvironment dampens immune responses to cancer, and blocking this axis induces antitumor... 
checkpoint | neuroblastoma | tumor‐infiltrating lymphocytes | programmed death 1/programmed death 1 ligand (PD‐1/PD‐L1) blockade | immunotherapy | pediatric cancer | tumor-infiltrating lymphocytes | programmed death 1/programmed death 1 ligand (PD-1/PD-L1) blockade | Life Sciences & Biomedicine | Oncology | Science & Technology | Immunohistochemistry | Bone Neoplasms - mortality | Tissue Array Analysis | Humans | Sarcoma, Ewing - pathology | Rhabdomyosarcoma - pathology | Neuroblastoma - mortality | Osteosarcoma - chemistry | Macrophages | Bone Neoplasms - pathology | Burkitt Lymphoma - pathology | Neoplasms - chemistry | Lymphocytes, Tumor-Infiltrating | Burkitt Lymphoma - immunology | Neuroblastoma - immunology | Bone Neoplasms - chemistry | Glioblastoma - chemistry | Child | Neuroblastoma - pathology | Rhabdomyosarcoma - immunology | Sarcoma, Ewing - chemistry | Neuroblastoma - chemistry | Neoplasms - mortality | Bone Neoplasms - immunology | Burkitt Lymphoma - chemistry | Sarcoma, Ewing - immunology | Osteosarcoma - immunology | Glioblastoma - immunology | Neoplasms - immunology | Glioblastoma - pathology | Neoplasm Proteins - analysis | B7-H1 Antigen - analysis | Rhabdomyosarcoma - chemistry | Neoplasms - pathology | Osteosarcoma - pathology | Chemotherapy | Usage | Care and treatment | Diagnosis | Research | Gene expression | Cancer in children | Cancer | Pediatrics | Parkinson's disease | PD-1 protein | Glioblastoma | Neuroblastoma | Tissues | Anticancer properties | Metastases | Lymphocytes | Children | Movement disorders | Immune system | Immune response | Neurodegenerative diseases | Tumor cells | Mortality | Patients | Survival | Glioblastoma multiforme | Lymphoma | Burkitt's lymphoma | PD-L1 protein | Biomarkers | Ligands | Death | Antitumor activity | Infiltration | Diagnostic systems | Tumors | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article